Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma

Ketty Peris, S Chimenti, S Di Cristofaro, Mc Fargnoli, G. Torlone

Risultato della ricerca: Contributo in rivistaArticolo in rivista

48 Citazioni (Scopus)

Abstract

Several neoplasms including cutaneous T-cell lymphomas, malignant melanoma and Kaposi's sarcoma have been successfully treated with systemic or intralesional interferons (IFNs). Recently, intralesional alpha-IFN has also been employed in the treatment of basal cell carcinoma (BCC).
Lingua originaleEnglish
pagine (da-a)214-217
Numero di pagine4
RivistaDermatology
Volume190
Stato di pubblicazionePubblicato - 1995

Keywords

  • Adult
  • Aged
  • Carcinoma, Basal Cell
  • Drug Administration Schedule
  • Fatigue
  • Female
  • Fever
  • Follow-Up Studies
  • Headache
  • Humans
  • Injections, Intralesional
  • Interferon-alpha
  • Male
  • Middle Aged
  • Nausea
  • Recombinant Proteins
  • Remission Induction
  • Skin Neoplasms

Fingerprint Entra nei temi di ricerca di 'Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma'. Insieme formano una fingerprint unica.

Cita questo